(Q43905884)

27 November 2017

Gut and liver handling of asymmetric and symmetric dimethylarginine in the rat under basal conditions and during endotoxemia (English)

1 reference

27 November 2017

Robert J Nijveldt

1

1 reference

27 November 2017

Michiel P C Siroen

2

1 reference

27 November 2017

Tom Teerlink

3

1 reference

27 November 2017

Antonie A van Lambalgen

4

1 reference

27 November 2017

Jan A Rauwerda

5

1 reference

27 November 2017

Paul A M van Leeuwen

6

1 reference

27 November 2017

1 October 2004

1 reference

27 November 2017

1 reference

27 November 2017

24

1 reference

27 November 2017

5

1 reference

27 November 2017

510-518

1 reference

Endogenous Dimethylarginine as an Inhibitor of Nitric Oxide Synthesis

27 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L‐arginine in regenerated endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

Urinary excretion of methylarginine in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

Detection of NG,NG-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

Arginine metabolism: nitric oxide and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

Renal function and oxygen consumption during bacteraemia and endotoxaemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

Organ blood flow and distribution of cardiac output in dopexamine- or dobutamine-treated endotoxemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

Effects of dobutamine and dopexamine on hepatic micro- and macrocirculation during experimental endotoxemia: an intravital microscopic study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

Total nitric oxide production is low in patients with chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

Dimethylarginines in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0948.X

10.1111/J.1478-3231.2004.0948.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference